Jahang, Catherine J.

HRN: 21-84-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2022
CEFUROXIME 500MG (TAB)
08/30/2022
09/06/2022
PO
500mg
Q12
S/P TC UTI
Waiting Final Action 
08/30/2022
CEFUROXIME 1.5GM (VIAL)
08/30/2022
08/31/2022
IV
1.5g
Q8
UTI

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: